drugset
drugset / Trial / NCT03753867

RA Effect on Cell Surface Molecules in Vivo

NCT03753867 ↗

Phase 1 Withdrawn Ottawa Hospital Research Institute
NaSingle-groupOpen-labelTreatment

Summary

This study will follow a group of healthy male participants for about 18 weeks to see the effect of taking Acitretin on their immune cells

Timeline

Start
2019-01-07
Primary completion
2019-05-08
Completion
2019-05-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Acitretin Small molecule 35 mg Oral

Indications

HIV infectious disease